LIVE EVENT Q&A: Dr. Andrew Huberman at the ICC Sydney Theatre

The episode opens by identifying the program as the Huberman Lab Podcast and introducing Andrew Huberman as a professor of neurobiology and ophthalmology at Stanford School of Medicine. What follows is the audience question-and-answer portion of a live event held at the ICC Theatre in Sydney, Australia. The event, called The Brain-Body Contract, combined a lecture with audience questions, and the Q&A was released so that people who could not attend could hear it.

Before the Q&A, the event's two sponsors are presented. Eight Sleep is described as making smart mattress covers with cooling, heating and sleep tracking. The pitch ties the product to temperature: body temperature is said to need to drop by about one to three degrees to fall and stay deeply asleep, and to rise by about one to three degrees to wake feeling refreshed. The newest Pod4 Ultra cover is described as having improved cooling and heating, higher-fidelity sleep tracking, and snoring detection that lifts the head a few degrees to improve airflow. The offer is $350 off via eightsleep.com/huberman, with shipping to the USA, Canada, the UK, select EU countries and Australia.

The second sponsor, AG1, is described as a vitamin, mineral and probiotic drink that also contains adaptogens and micronutrients. The speaker says they have taken it daily since 2012, once or twice a day, as a way to cover nutritional gaps when eating mostly unprocessed or minimally processed whole foods is hard, especially while traveling or busy. The read frames AG1 as foundational nutritional support rather than a supplement aimed at one outcome such as sleep or alertness, and links it to gut health, immune health and brain health. These are sponsor claims, presented as such in the ad. The offer through drinkag1.com/huberman is five free travel packs plus a year's supply of vitamin D3K2.

The first audience question asks whether an afternoon sleep affects sleep quality at night. The answer is framed as brief, and references a six-episode series recorded with Matt Walker, author of Why We Sleep, said to air later in the year, in which the topic was covered in depth.

Keep them shorter than 90 minutes so you don't disrupt your nighttime sleep. Don't do them at all if it disrupts your nighttime sleep.

The guidance is conditional rather than universal. Naps under 90 minutes are presented as compatible with nighttime sleep, but anyone for whom even 10 minutes of napping disrupts night sleep is told not to nap. Waking from a nap feeling groggy is identified as sleep inertia, which the speaker says gave rise to the "napuccino": having coffee or an espresso before napping. The speaker briefly digresses on the name, wondering why it was not called an espresso nap.

The answer then turns to non-sleep deep rest, described as putting the body into a state of "Body still, mind awake." The speaker cites several studies from the University of Copenhagen as showing that this state replenishes dopamine in certain key brain areas tied to mental and physical vigor, and that it does not disrupt nighttime sleep but rather enhances the ability to fall asleep, stay asleep or fall back asleep.

There is an explicit distinction between the strength of different claims. A possible benefit for creativity is hedged, with the speaker noting that it rested on anecdotal data (rendered in the transcript as "anic data"). By contrast, the claim that a still-body, alert-mind state improves sleep is attributed to laboratory data on many subjects that was peer reviewed. Even there, the further idea that it might make up for lost sleep is qualified with "perhaps."

The practical suggestion is that nappers are fine continuing, but people who suspect their napping is linked to sleep problems could consider short 10- or 20-minute non-sleep deep rest protocols instead, which are described as zero cost. The speaker mentions upcoming narrated 10-, 20- and 30-minute protocols for the YouTube clips channel, with a visual of a sunrise over Sydney, and acknowledges that listeners who dislike the narrator's voice can find other versions.

Asked whether they believe in the placebo effect, the speaker answers "Absolutely" and states that the placebo effect is real. The central claim is that beliefs act on the body.

Our belief about what we've taken or what is happening to us has a powerful effect on our physiology.

The speaker adds that this is "not purely psychological," and argues that the very concept of "psychosomatic" is starting to fall away as researchers understand how strongly beliefs shape physiological outcomes.

The first line of evidence comes from Ali Crum, described as a tenured professor in Stanford's Department of Psychology who studies mindsets and has been a guest on the podcast. In her stress experiments as described here, people who watched a short video about the harms of stress to cognition, sleep and well-being experienced those effects, while people who watched a short video about stress sharpening mental acuity and access to memory experienced those enhancements instead.

The speaker draws a terminological distinction: these are "belief effects," which tend to concern specific types of information, whereas placebo effects tend to be more general.

The second line of evidence is a study the speaker calls one of the more remarkable papers of the last few years, discussed previously in a Journal Club episode with Peter Attia (transcribed as "Atiyah"). The dose figures are given with stated uncertainty: participants took either zero, "I believe it was 0.25 milligrams," half a milligram or a gram of nicotine. Nicotine is described as a known cognitive enhancer, but with explicit cautions: smoking, dipping, huffing or snuffing it is called cancerous in those forms, and taking nicotine can raise blood pressure and cause vasoconstriction.